Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ: MIRM · Real-Time Price · USD

99.88

-1.03 (-1.02%)

At close: Feb 11, 2026, 4:00 PM EST

100.87

+0.99 (0.99%)

Pre-market: Feb 12, 2026, 7:32 AM EST

Mirum Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5,981	1,985	1,376	719	486	511
Market Cap Growth	156.67%	44.25%	91.51%	47.79%	-4.80%	-7.70%
Enterprise Value	5,924	2,018	1,378	535	299	380
Last Close Price	99.88	41.35	29.52	19.50	15.95	17.46
PS Ratio	10.45	5.89	7.38	9.32	25.41	-
PB Ratio	17.55	8.80	5.53	5.06	4.04	2.97
P/TBV Ratio	99.43	-	-	8.65	4.79	2.97
P/FCF Ratio	134.95	212.71	-	-	-	-
P/OCF Ratio	133.82	192.25	-	-	-	-
EV/Sales Ratio	12.56	5.99	7.39	6.95	15.62	-
EV/FCF Ratio	133.67	216.27	-	-	-	-
Debt / Equity Ratio	1.09	1.41	1.24	0.02	0.02	0.02
Debt / FCF Ratio	7.19	34.05	-	-	-	-
Asset Turnover	0.65	0.51	0.37	0.24	0.07	-
Inventory Turnover	4.16	3.65	3.38	3.50	-	-
Quick Ratio	3.01	2.83	4.07	2.72	3.76	12.56
Current Ratio	3.31	3.10	4.45	2.94	3.91	12.80
Return on Equity (ROE)	-15.81%	-37.08%	-83.65%	-103.46%	-57.47%	-68.29%
Return on Assets (ROA)	-3.60%	-8.31%	-13.65%	-25.33%	-40.48%	-33.64%
Return on Capital Employed (ROCE)	-6.70%	-16.10%	-19.50%	-45.50%	-68.80%	-46.90%
Earnings Yield	-0.69%	-4.43%	-11.88%	-18.88%	-17.27%	-20.22%
FCF Yield	0.74%	0.47%	-5.16%	-16.76%	-27.31%	-17.48%
Buyback Yield / Dilution	-4.69%	-16.23%	-20.31%	-12.07%	-20.08%	-119.84%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q